ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
The results of randomized clinical trials comprising SMILE (The Survival of Myocardial Infarction Long term Evaluation) Project were analyzed. Six-week therapy with an ACE inhibitor zofenopril in acute myocardial infarction (AMI) patients resulted in one-year mortality reduction by 29%. Xofenopril w...
Main Author: | Yu. M. Lopatin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2006-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1168 |
Similar Items
-
Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease
by: C. Napoli
Published: (2011-12-01) -
Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.
by: Lyudmila Gennadievna Ratova, et al.
Published: (2009-09-01) -
ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01) -
POTENTIAL OF THE MODERN ACE INHIBITOR ZOFENOPRIL IN CLINICAL PRACTICE: CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTIATHEROGENIC EFFECTS
by: M. G. Bubnova
Published: (2013-02-01) -
Clinical role of cardioprotective and vasculoprotective effects of АСЕ inhibitors in myocardial infarction: zofenopril
by: G. K. Кiyakbaev
Published: (2008-12-01)